EA200200682A1 - Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие - Google Patents
Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащиеInfo
- Publication number
- EA200200682A1 EA200200682A1 EA200200682A EA200200682A EA200200682A1 EA 200200682 A1 EA200200682 A1 EA 200200682A1 EA 200200682 A EA200200682 A EA 200200682A EA 200200682 A EA200200682 A EA 200200682A EA 200200682 A1 EA200200682 A1 EA 200200682A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- group
- benzylpiperasine
- receiving
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Abstract
Настоящее изобретение относится к соединениям формулы (I)в которой Rпредставляет собой алкильную группу, Rпредставляет собой гидрокси, алкокси, или аминогруппу, n представляет собой коэффициент от 1 до 12 включительно, Rпредставляет собой атом водорода, необязательно замещенную алкильную группу, циклоалкильную группу, пиримидинильную группу или необязательно замещенную фенильную группу,их изомерам и аддитивным солям с фармацевтически приемлемой кислотой или основанием. Лекарственные препараты.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0109454A FR2827284B1 (fr) | 2001-07-16 | 2001-07-16 | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200200682A1 true EA200200682A1 (ru) | 2003-02-27 |
EA005165B1 EA005165B1 (ru) | 2004-12-30 |
Family
ID=8865549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200200682A EA005165B1 (ru) | 2001-07-16 | 2002-07-15 | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие |
Country Status (23)
Country | Link |
---|---|
US (1) | US6686360B2 (ru) |
EP (1) | EP1277746B1 (ru) |
JP (1) | JP2003096057A (ru) |
KR (1) | KR100498867B1 (ru) |
CN (1) | CN1397554A (ru) |
AR (1) | AR034779A1 (ru) |
AT (1) | ATE295358T1 (ru) |
AU (1) | AU2002300150B2 (ru) |
BR (1) | BR0202686A (ru) |
CA (1) | CA2394010A1 (ru) |
DE (1) | DE60204083T2 (ru) |
DK (1) | DK1277746T3 (ru) |
EA (1) | EA005165B1 (ru) |
ES (1) | ES2241973T3 (ru) |
FR (1) | FR2827284B1 (ru) |
HU (1) | HUP0202293A3 (ru) |
MX (1) | MXPA02006900A (ru) |
NO (1) | NO20023409L (ru) |
NZ (1) | NZ520173A (ru) |
PL (1) | PL355066A1 (ru) |
PT (1) | PT1277746E (ru) |
SI (1) | SI1277746T1 (ru) |
ZA (1) | ZA200205666B (ru) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8174436B2 (en) | 2002-07-08 | 2012-05-08 | American Underwater Products, Inc. | Dive computer with global positioning system receiver |
US9443039B2 (en) | 2002-07-08 | 2016-09-13 | Pelagic Pressure Systems Corp. | Systems and methods for dive computers with remote upload capabilities |
JPWO2004101529A1 (ja) * | 2003-05-19 | 2006-07-13 | 小野薬品工業株式会社 | 含窒素複素環化合物およびその医薬用途 |
FR2883876B1 (fr) * | 2005-03-30 | 2007-05-04 | Servier Lab | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US7797124B2 (en) | 2006-12-28 | 2010-09-14 | American Underwater Products, Inc. | Dive computer with free dive mode and wireless data transmission |
US9821893B2 (en) | 2014-10-06 | 2017-11-21 | Pelagic Pressure Systems Corp. | System and methods for configurable dive masks with multiple interfaces |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2661176B1 (fr) * | 1990-04-20 | 1992-06-12 | Adir | Nouveau procede de preparation de la 1-(2,3,4-trimethoxybenzyl) piperazine en amination reductive. |
JPH04356473A (ja) * | 1991-05-31 | 1992-12-10 | Wako Pure Chem Ind Ltd | ベンジルピペラジン誘導体の新規製造法 |
FR2681324B1 (fr) * | 1991-09-18 | 1993-10-29 | Adir Cie | Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant. |
FR2703048B1 (fr) * | 1993-03-24 | 1996-01-05 | Adir | Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
FR2757164B1 (fr) * | 1996-12-16 | 1999-01-22 | Adir | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6479495B1 (en) * | 1997-09-29 | 2002-11-12 | Aventis Pharmaceuticals Inc. | Aminoalkylphenol derivatives and related compounds |
-
2001
- 2001-07-16 FR FR0109454A patent/FR2827284B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-12 MX MXPA02006900A patent/MXPA02006900A/es active IP Right Grant
- 2002-07-12 BR BR0202686-4A patent/BR0202686A/pt not_active Application Discontinuation
- 2002-07-15 JP JP2002205661A patent/JP2003096057A/ja active Pending
- 2002-07-15 NO NO20023409A patent/NO20023409L/no unknown
- 2002-07-15 AR ARP020102635A patent/AR034779A1/es unknown
- 2002-07-15 EA EA200200682A patent/EA005165B1/ru not_active IP Right Cessation
- 2002-07-15 HU HU0202293A patent/HUP0202293A3/hu unknown
- 2002-07-15 NZ NZ520173A patent/NZ520173A/en not_active IP Right Cessation
- 2002-07-15 KR KR10-2002-0041113A patent/KR100498867B1/ko not_active IP Right Cessation
- 2002-07-16 PL PL02355066A patent/PL355066A1/xx not_active Application Discontinuation
- 2002-07-16 US US10/195,948 patent/US6686360B2/en not_active Expired - Fee Related
- 2002-07-16 SI SI200230129T patent/SI1277746T1/xx unknown
- 2002-07-16 EP EP02291784A patent/EP1277746B1/fr not_active Expired - Lifetime
- 2002-07-16 ZA ZA200205666A patent/ZA200205666B/xx unknown
- 2002-07-16 CN CN02124182A patent/CN1397554A/zh active Pending
- 2002-07-16 ES ES02291784T patent/ES2241973T3/es not_active Expired - Lifetime
- 2002-07-16 PT PT02291784T patent/PT1277746E/pt unknown
- 2002-07-16 DE DE60204083T patent/DE60204083T2/de not_active Expired - Lifetime
- 2002-07-16 AT AT02291784T patent/ATE295358T1/de active
- 2002-07-16 DK DK02291784T patent/DK1277746T3/da active
- 2002-07-16 CA CA002394010A patent/CA2394010A1/fr not_active Abandoned
- 2002-07-16 AU AU2002300150A patent/AU2002300150B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
DK1277746T3 (da) | 2005-08-29 |
EP1277746A2 (fr) | 2003-01-22 |
FR2827284B1 (fr) | 2003-10-31 |
KR20030007187A (ko) | 2003-01-23 |
ES2241973T3 (es) | 2005-11-01 |
CA2394010A1 (fr) | 2003-01-16 |
MXPA02006900A (es) | 2010-11-17 |
HUP0202293A3 (en) | 2004-04-28 |
AR034779A1 (es) | 2004-03-17 |
NZ520173A (en) | 2004-02-27 |
BR0202686A (pt) | 2003-05-06 |
CN1397554A (zh) | 2003-02-19 |
NO20023409L (no) | 2003-01-17 |
US6686360B2 (en) | 2004-02-03 |
KR100498867B1 (ko) | 2005-07-04 |
EP1277746A3 (fr) | 2003-08-13 |
ATE295358T1 (de) | 2005-05-15 |
JP2003096057A (ja) | 2003-04-03 |
PT1277746E (pt) | 2005-07-29 |
EA005165B1 (ru) | 2004-12-30 |
NO20023409D0 (no) | 2002-07-15 |
AU2002300150B2 (en) | 2007-10-11 |
EP1277746B1 (fr) | 2005-05-11 |
HUP0202293A2 (hu) | 2003-04-28 |
DE60204083D1 (de) | 2005-06-16 |
ZA200205666B (en) | 2003-03-27 |
FR2827284A1 (fr) | 2003-01-17 |
HU0202293D0 (ru) | 2002-09-28 |
DE60204083T2 (de) | 2006-03-16 |
US20030158207A1 (en) | 2003-08-21 |
PL355066A1 (en) | 2003-01-27 |
SI1277746T1 (ru) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL150650A0 (en) | Piperidine derivatives and pharmaceutical compositions containing the same | |
TW200724136A (en) | Pharmaceutical compositions comprising PPAR modulator | |
BRPI0211844B8 (pt) | composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica | |
EA200200942A1 (ru) | Фармацевтические композиции, содержащие производные 3-аминоазетидина, новые производные и способ их получения | |
DE60124504D1 (de) | Stabile emulsionszubereitungen | |
EA200870321A1 (ru) | Способ получения 4-оксохинолинового соединения | |
TW200611687A (en) | Pharmaceutical compositions used for immunosuppressant | |
CA2475432A1 (en) | 2,4,6-triamino-1,3,5-triazine derivative | |
PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
EP1775289A4 (en) | NEW IMIDAZOLIDINE DERIVATIVES | |
EA200300927A1 (ru) | Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
EA200200682A1 (ru) | Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие | |
EA200400806A1 (ru) | Способ получения эхинокандиновых соединений | |
EA200101230A1 (ru) | Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции | |
AR044175A1 (es) | Compuestos de cefemo | |
EA200000068A3 (ru) | Новые цианоиндольные соединения, являющиеся ингибиторами повторного захвата серотонина, способ их получения и фармацевтические композиции, содержащие их | |
MX9206930A (es) | Nuevos compuestos | |
EA200500716A1 (ru) | Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат | |
EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции | |
EA200400533A1 (ru) | Новые соединения гидроксиалкилиндолокарбазола, способ их получения и фармацевтические композиции, которые их содержат | |
EA200301171A1 (ru) | Новые соединения трициклических дигидрохинолинов, способ их получения и фармацевтические композиции, содержащие их | |
EA200900480A1 (ru) | Новые соединения индола, способ их получения и фармацевтические композиции, которые их содержат | |
EA200000598A1 (ru) | Новые ингибиторы металлопротеазы, способ их получения и содержащие их фармацевтические композиции | |
MY136065A (en) | Prodrugs to nmda receptor ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |